Professor of Obstetrics and Gynecology, University Okla College of Medicine
Obstetrics & Gynecology
Dr. Robert S. Mannel, MD
|
|
Give Review
Robert Mannel practices Obstetrics & Gynecology. He over the years received 5 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Oklahoma Magazine", "Fellow (FACOG)" and "Fellow (FACS)". Doctor Robert S. Mannel, MD is a published doctor and has 50 publications published. The lastest was: 'Is the NCI MATCH Trial a Match for Gynecologic Oncology?' Robert Mannel accepts Medicare payments and is registered with Medicare.gov.
Publications
- Is the NCI MATCH Trial a Match for Gynecologic Oncology?
- Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gyn...
- Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenoCarcinoma: a gynecologic oncology group study.
- Anti-angiogenic Therapy Versus Dose-Dense Paclitaxel Therapy for Frontline Treatment of Epithelial Ovarian Cancer: Review of Phase III Randomized Clinical Trials.
- A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: An NRG Oncology/Gynecologic On...
- SGO guidance document for clinical trial designs in ovarian Cancer: A changing paradigm.
- Pemetrexed and Cisplatin for the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix: A Limited Access Phase II Trial of the Gynecologic Oncology G...
- Ovarian Cancer Clinical Trial Endpoints: Society of Gynecologic Oncology White Paper.
- Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial Cancer patients with high-intermediate risk factors.
- Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian Cancer: a Gynecologic Oncology Group Study.
- A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial Cancer: A Gynecologic Oncology Group study.
- Selumetinib in women with recurrent low-grade serous Carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.
- A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal Carcinomas: A Gynecologic Oncol...
- Uterine Serous Carcinoma: Increased Familial Risk for Lynch-Associated Malignancies.
- A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients wit...
- Association of number of positive nodes and Cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiati...
- A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal Carcinoma: A gynecologic oncology group study.
- Anti-angiogenic therapy in ovarian Cancer; what is the best population?
- Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, Fallopian tube, and prim...
- Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial Ovarian and pr...
- Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube Cancer.
- A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, Fallopian tube, and p...
- A randomized phase III trial of IV carboplatin and paclitaxel à 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-...
- A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic valu...
- Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
- Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal Carcinoma ...
- A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovaria...
- Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
- A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal Cancer: a gynecologic oncology gr...
- Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine Cancer: Gynecologic Oncology Group Study LAP2.
- Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal Carcinoma: a study of the Gynecologic On...
- Adjuvant chemotherapy for the "oldest old" ovarian Cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?
- Sequential chemotherapy and irradiation in advanced stage endometrial Cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abd...
- Ovarian Cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
- A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage...
- Treatment of ("bulky") stage IB Cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic ly...
- Staffing for hospital lactation programs: recommendations from a tertiary care teaching hospital.
- Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone.
- Carcinosarcoma of the ovary-a case series.
- Gynecologic oncologists' perceptions of fellowship training.
- A comparison of stages IB1 and IB2 Cervical cancers treated with radical hysterectomy. Is size the real difference?
- Surgical-pathological predictors of disease-free survival and risk groupings for IB2 Cervical cancer: do the traditional models still apply?
- Outpatient implantation of a central venous access system in gynecologic oncology patients.
- Prolonged oral etoposide in recurrent or advanced non-squamous cell Carcinoma of the cervix: a Gynecologic Oncology Group study.
- Impact of individual physicians on enrollment of patients into clinical trials.
- Ascites as a predictor of Ovarian malignancy.
- Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous Carcinoma of the cervix: a gynecologic oncology group study.
- Laparoscopic Pelvic and paraaortic lymph node dissection in the obese.
- Method and timing of tumor volume measurement for outcome prediction in Cervical cancer using magnetic resonance imaging.
Schools
University of Texas At Galveston Medical Branch
Scott White Hospital
UC Irvine
Procedures Preformed
- Colposcopy
- EndoCervical Curettage
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Gynecologic Cancer Screening
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Chronic Pelvic Pain
- Endometriosis
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Oklahoma Magazine
- Fellow (FACOG)
- Fellow (FACS)
Education
-
University of California Irvine -
Texas A&M - Scott and White Memorial Hospital -
University of Texas Medical Branch
Helpful Reviews
Similar Doctors
|
Dr. Jeffrey J. Smith, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Latasha B. Craig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joan L. Walker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa M. Landrum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip J. Maguire, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Donna Seres, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Melendez, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Larry Houk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen N. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel Fong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel C. Schultz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lee P. Frye, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nancy M. Bishop, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald S. McMeekin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kaitlin Hoover, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amber Weingartner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nareshkumar G. Patel, MD
This Doctor is OpenDoctor Recommended.
|